CalciMedica, Inc. is a clinical-stage biopharmaceutical company, which engages in developing therapies for life-threatening inflammatory diseases. The firm's product candidate, Auxora, helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
16
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. CalciMedica Inc market cap is $8.69M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. CalciMedica Inc 52 week high is $36.00 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. CalciMedica Inc 52 week low is $1.00 as of November 21, 2026.
CalciMedica Inc stock price today is $1.26.
CalciMedica Inc stock price yesterday was $1.17.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. CalciMedica Inc's P/E ratio is -0.28.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. CalciMedica Inc P/B ratio is 2.0552.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. CalciMedica Inc 50-day moving average is $1.44.